|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Investments, at fair value (amortized cost $594,296 and $607,574, respectively) | ||||||||||||||||
| Non-controlled/non-affiliate company investments | ||||||||||||||||
| Non-controlled affiliate company investments | ||||||||||||||||
| Controlled affiliate company investments | ||||||||||||||||
| Total investments, at fair value (amortized cost $594,296 and $607,574, respectively) | ||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||
| Restricted cash and cash equivalents | ||||||||||||||||
| Restricted foreign currency (cost of $123 and $405, respectively) | ||||||||||||||||
| Interest and dividend receivable | ||||||||||||||||
| Amounts receivable on unsettled investment transactions | ||||||||||||||||
| Escrow receivable | ||||||||||||||||
| Prepaid expenses and other receivables | ||||||||||||||||
| Unrealized appreciation on foreign currency forward contracts | ||||||||||||||||
| Total assets | ||||||||||||||||
| Liabilities | ||||||||||||||||
| Debt (net of unamortized debt issuance costs of $4,051 and $4,666, respectively) | ||||||||||||||||
| Distributions payable | ||||||||||||||||
| Management fees payable | ||||||||||||||||
| Incentive fees payable | ||||||||||||||||
| Amounts payable on unsettled investment transactions | ||||||||||||||||
| Interest payable | ||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||
| Advances received from unfunded credit facilities | ||||||||||||||||
| Unrealized depreciation on foreign currency forward contracts | ||||||||||||||||
| Amounts payable for common stock repurchased | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Net assets | ||||||||||||||||
| Common stock, 21,476,471 and 22,234,045 shares issued and outstanding, par value $0.001 per share, respectively, and 100,000,000 shares authorized | ||||||||||||||||
| Paid-in capital in excess of par | ||||||||||||||||
| Accumulated earnings (losses) | ||||||||||||||||
| Total net assets | ||||||||||||||||
| Total liabilities and total net assets | ||||||||||||||||
| Number of shares outstanding | ||||||||||||||||
| Net asset value per share |
Loading...
